NCT00771498 - An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

HIV InfectionTuberculosis

Interventions

DRUG

Lopinavir

ARV treatment: 2 NRTIs + lopinavir/r 800mg / 200 mg (4 tablets of Kaletra) every 12 hours, daily and orally Antituberculosis treatment: rifampin (600 mg/daily) + isoniazide (400 mg/daily) for 6 months, both in fasting condition + pirazinamide (2000 mg) for the first two months

Trial Locations (3)

Unknown

University of Espirito Santo, Vitória

Instituto de Pesquisa Clinica Evandro Chagas (IPEC), Rio de Janeiro

Instituto Oswaldo Cruz (IOC), Rio de Janeiro